These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 4290198)

  • 1. [New model studies of intestinal defenses against infection].
    Raettig H
    Zentralbl Bakteriol Orig; 1965 Dec; 198(1):206-11. PubMed ID: 4290198
    [No Abstract]   [Full Text] [Related]  

  • 2. [Provocation of an infection through vaccination. X. Prevention of viral infection provocation through oral immunization with inactivated virus during the incubation period].
    Raettig H
    Zentralbl Bakteriol Orig; 1966 Aug; 200(4):448-59. PubMed ID: 4295196
    [No Abstract]   [Full Text] [Related]  

  • 3. [On active immunization against salmonelloses].
    Illés J
    Zentralbl Bakteriol Orig; 1967 Feb; 202(3):364-8. PubMed ID: 4878031
    [No Abstract]   [Full Text] [Related]  

  • 4. [Possibilities and limits of vaccinations].
    Schneeweiss B
    Z Arztl Fortbild (Jena); 1971 May; 65(9-10):485-95. PubMed ID: 5114862
    [No Abstract]   [Full Text] [Related]  

  • 5. The use of live attenuated Salmonella for oral vaccination.
    Chatfield S; Roberts M; Li J; Starns A; Dougan G
    Dev Biol Stand; 1994; 82():35-42. PubMed ID: 7958481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Studies and control of oral antityphoid vaccines].
    De Caro M; Samarani E
    Prog Immunobiol Stand; 1970; 4():369-71. PubMed ID: 4921391
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative efficacy of whole and disintegrated killed vaccines against Salmonella typhimurium in mice.
    Cronly-Dillon S
    J Med Microbiol; 1972 May; 5(2):183-9. PubMed ID: 4555727
    [No Abstract]   [Full Text] [Related]  

  • 8. Systemic and mucosal immunity induced by oral somatic transgene vaccination against glycoprotein B of pseudorabies virus using live attenuated Salmonella typhimurium.
    Eo SK; Yoon HA; Aleyas AG; Park SO; Han YW; Chae JS; Lee JH; Song HJ; Cho JG
    FEMS Immunol Med Microbiol; 2006 Aug; 47(3):451-61. PubMed ID: 16872383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salmonella enterica serovar Typhimurium strain lacking pmrG-HM-D provides excellent protection against salmonellosis in murine typhoid model.
    Negi VD; Singhamahapatra S; Chakravortty D
    Vaccine; 2007 Jul; 25(29):5315-23. PubMed ID: 17574312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The significance of protection tests in mice for evaluating typhoid vaccines.
    Sterne M; Trim G
    Prog Immunobiol Stand; 1971; 5():382-8. PubMed ID: 4573946
    [No Abstract]   [Full Text] [Related]  

  • 11. [Vaccines inf the prevention of fecal hazards].
    Saliou P
    Bull Soc Pathol Exot; 1998; 91(5 Pt 1-2):445-9. PubMed ID: 10078383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Typhoid-paratyphoid (TAB) vaccine as interferon inducer in mice.
    Kandefer-Szerszeń M
    Acta Microbiol Pol A; 1973; 5(3):156-62. PubMed ID: 4358715
    [No Abstract]   [Full Text] [Related]  

  • 13. Mucosal vaccination with a recombinant Salmonella typhimurium expressing human papillomavirus type 16 (HPV16) L1 virus-like particles (VLPs) or HPV16 VLPs purified from insect cells inhibits the growth of HPV16-expressing tumor cells in mice.
    Revaz V; Benyacoub J; Kast WM; Schiller JT; De Grandi P; Nardelli-Haefliger D
    Virology; 2001 Jan; 279(1):354-60. PubMed ID: 11145916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Typhoid vaccination from an immunological point of view].
    Günther O
    Arb Paul Ehrlich Inst Georg Speyer Haus Ferdinand Blum Inst Frankf A M; 1970; 65():1-14. PubMed ID: 4926019
    [No Abstract]   [Full Text] [Related]  

  • 15. Problems of anti-typhoid immunity and protective vaccination against typhoid.
    Karolcek J
    Lek Pr; 1969; 7(1):3-153. PubMed ID: 4917329
    [No Abstract]   [Full Text] [Related]  

  • 16. Compatible concurrent administration of yellow fever 17D vaccine with oral, live, attenuated p6olera CVD103-HgR and typhoid ty21a vaccines.
    Tsai TF; Kollaritsch H; Que JU; Cropp CB; Kunz C; Wiedermann G; Herzog C; Cryz SJ
    J Infect Dis; 1999 Feb; 179(2):522-4. PubMed ID: 9878043
    [No Abstract]   [Full Text] [Related]  

  • 17. [Vaccination status of French and European travelers: a study of 9,156 subjects departing from Paris to 12 tropical destinations].
    Prazuck T; Semaille C; Defayolle M; Bargain P; Clerel M; Lafaix C; Santin A; Fisch A
    Rev Epidemiol Sante Publique; 1998 Feb; 46(1):64-7. PubMed ID: 9533236
    [No Abstract]   [Full Text] [Related]  

  • 18. [Vaccination against diarrheal diseases and typhoid fever. Current status and prospects].
    Ivanoff B; Neira M
    Ann Med Interne (Paris); 1998 Oct; 149(6):340-50. PubMed ID: 9853044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anomalous observations on IPV and OPV vaccination.
    John TJ
    Dev Biol (Basel); 2001; 105():197-208. PubMed ID: 11763328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral delivery of DNA vaccine encoding VP28 against white spot syndrome virus in crayfish by attenuated Salmonella typhimurium.
    Ning JF; Zhu W; Xu JP; Zheng CY; Meng XL
    Vaccine; 2009 Feb; 27(7):1127-35. PubMed ID: 19071178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.